CHORUS Alpha Version: A Major Milestone for Collaborative Biomedical Research and AI Development

On June 12, 2025, CHORUS entered its alpha phase, marking an important milestone in building an open-source platform for secure, collaborative biomedical research and AI development. This early version allows users to create project-dedicated workspaces where they can manage their work by activity and team through dedicated sessions. Within each session, they can launch relevant applications such as DiData, JupyterLab, or VSCode, tailored to their specific research needs.

CHORUS is built on proven technologies and user-focused innovation. It leverages the Human Intracerebral Platform (HIP), developed by the NeuroDigital team at CHUV and applied in neuroscience research. Development began in January 2024 and is guided by a User Advisory Board of experts in research, data management, engineering, data science, and AI. This collaborative, user-centered approach keeps CHORUS intuitive, effective, and responsive. The platform is designed to deliver both scalability and reliability, ensuring it can grow alongside the evolving needs of the scientific community.

Looking Ahead: The Beta Version

The next development phase is already underway. The upcoming beta version will introduce essential functionalities to enhance the platform’s usability and scope:

• Authentication and Authorization: A robust system to verify users and control access based on roles and permissions.
• Data Access: Integration of a data management to streamline data exploration and retrieval.
• App Store: A space to search, select, and add new applications, empowering researchers to tailor their workspaces to specific needs. 

Join the CHORUS Journey

As development moves forward, we invite you to explore the alpha version, visit our new website, browse the user documentation, and read more about what’s coming next. While the current platform is still basic, this launch marks the beginning of a collaborative journey.